Innate Pharma Files 6-K Report
Ticker: IPHYF · Form: 6-K · Filed: Apr 3, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure
TL;DR
Innate Pharma dropped a 6-K filing on April 3rd, likely with news.
AI Summary
Innate Pharma SA filed a Form 6-K on April 3, 2025, reporting a press release dated the same day. The company, based in Marseille, France, is a biopharmaceutical company focused on biological products.
Why It Matters
This filing indicates a routine disclosure by Innate Pharma, likely containing updates or announcements relevant to investors and stakeholders.
Risk Assessment
Risk Level: low — This is a standard SEC filing (6-K) which typically contains routine disclosures and press releases, not usually indicative of immediate high risk.
Key Numbers
- 6-K — SEC Filing Type (Indicates a report of foreign private issuers.)
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- April 3, 2025 (date) — Filing date and press release date
- 001-39084 (other) — SEC File Number
- Marseille, France (location) — Company headquarters
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that are required to furnish information which they have made or are required to make public pursuant to the laws of their home country or a foreign stock exchange or that they have submitted or will submit to their security holders.
What specific exhibit is mentioned in this 6-K filing?
Exhibit 99.1 is mentioned, which is a Press Release dated April 3, 2025.
What is Innate Pharma SA's Standard Industrial Classification (SIC) code?
Innate Pharma SA's SIC code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the fiscal year end for Innate Pharma SA?
The fiscal year end for Innate Pharma SA is December 31 (1231).
Does Innate Pharma SA file annual reports under Form 20-F or Form 40-F?
Innate Pharma SA indicates it files annual reports under Form 20-F, as noted by the checkmark next to 'Form 20-F [X]'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 3, 2025 regarding Innate Pharma SA (IPHYF).